Signs of positive selection of somatic mutations in human cancers detected by EST sequence analysis
暂无分享,去创建一个
Eugene V Koonin | Fyodor A Kondrashov | E. Koonin | F. Kondrashov | I. Rogozin | V. Babenko | M. K. Basu | Igor B Rogozin | Vladimir N Babenko | Malay K Basu
[1] T. Vincent,et al. An evolutionary model of carcinogenesis. , 2003, Cancer research.
[2] M. Hsiao,et al. Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness. , 1994, The American journal of pathology.
[3] K. Kinzler,et al. Genetic instabilities in human cancers , 1998, Nature.
[4] M. Blagosklonny,et al. p53 from complexity to simplicity: mutant p53 stabilization, gain‐of‐function, and dominant‐negative effect , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[6] T R Skopek,et al. Statistical test for the comparison of samples from mutational spectra. , 1987, Journal of molecular biology.
[7] G. Lozano,et al. Disrupting TP53 in mouse models of human cancers , 2003, Human mutation.
[8] Liqing Zhang,et al. Human SNPs reveal no evidence of frequent positive selection. , 2005, Molecular biology and evolution.
[9] G. Glazko,et al. P53 Gain-of-Function: Tumor Biology and Bioinformatics Come Together , 2005, Cell cycle.
[10] Theodor Boveri. Zur Frage der Entstehung maligner Tumoren , 1914 .
[11] S. Haas,et al. Strengths and weaknesses of EST-based prediction of tissue-specific alternative splicing , 2004, BMC Genomics.
[12] Illinois.,et al. Cancer Genetics , 1976, British Journal of Cancer.
[13] K. Kinzler,et al. Cancer-susceptibility genes. Gatekeepers and caretakers. , 1997, Nature.
[14] K. Kinzler,et al. Cancer genes and the pathways they control , 2004, Nature Medicine.
[15] P. Vineis. Cancer as an evolutionary process at the cell level: an epidemiological perspective. , 2003, Carcinogenesis.
[16] Jarle Breivik,et al. The evolutionary origin of genetic instability in cancer development. , 2005, Seminars in cancer biology.
[17] A. Levine,et al. The p53 pathway: positive and negative feedback loops , 2005, Oncogene.
[18] G. Glazko,et al. Mutation hotspots in the p53 gene in tumors of different origin: correlation with evolutionary conservation and signs of positive selection. , 2004, Biochimica et biophysica acta.
[19] Christopher J. Lee,et al. Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. , 2003, Nucleic acids research.
[20] Zhongming Zhao,et al. Investigating single nucleotide polymorphism (SNP) density in the human genome and its implications for molecular evolution. , 2003, Gene.
[21] D. Labie,et al. Molecular Evolution , 1991, Nature.
[22] Luquan Wang,et al. Genome wide in silico SNP-tumor association analysis , 2004, BMC Cancer.
[23] L. Strong,et al. Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome , 2004, Cell.
[24] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[25] G D Schuler,et al. A workbench for multiple alignment construction and analysis , 1991, Proteins.
[26] L. Hurst. The Ka/Ks ratio: diagnosing the form of sequence evolution. , 2002, Trends in genetics : TIG.
[27] G. Sermonti. The human genome. , 1988, Rivista di biologia.
[28] A. Levine,et al. Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil , 2002, Oncogene.
[29] I. Hickson,et al. Caretaker tumour suppressor genes that defend genome integrity. , 2002, Trends in molecular medicine.
[30] M. Blagosklonny,et al. Molecular theory of cancer , 2005, Cancer biology & therapy.
[31] C Lengauer,et al. Genetic instability and darwinian selection in tumours. , 1999, Trends in cell biology.
[32] Adams Wt,et al. Statistical test for the comparison of samples from mutational spectra , 1987 .
[33] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[34] Jennifer Daub,et al. Expressed sequence tags: medium-throughput protocols. , 2004, Methods in molecular biology.
[35] Marcio Luis Acencio,et al. The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] A. Levine,et al. Gain of function mutations in p53 , 1993, Nature Genetics.
[37] T. Jacks,et al. Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome , 2004, Cell.
[38] D. Lane,et al. p53: oncogene or anti-oncogene? , 1990, Genes & development.
[39] M. Boguski,et al. dbEST — database for “expressed sequence tags” , 1993, Nature Genetics.